The Latest Breaking News from Sinovac

Antibodies are less effective in protecting people from the stronger, now-dominant BA.5 sub-variant of Covid-19, according to the Department of Medical Sciences.

Key Takeaways: CanSino’s Covid-19 vaccine Convidecia will be admitted to the global Covax program following its approval by the WHO The approval could have limited benefits for the company as the pandemic fades and other products are widely available By Jony Ho

China, the country that first detected the novel coronavirus, remains one of the few not to have imported one of the exceptionally effective mRNA COVID vaccines developed by Pfizer and Moderna. Instead, it has so far relied on vaccines developed by two Chinese companies, Sinovac and Sinopharm. However, this may…

Most of the vaccinated in the archipelago have been given the Sinovac shot.

A Public Health Ministry sub-committee on immunity promotion has approved the use of Sinovac's Covid-19 vaccine on minors over the age of three, it was announced on Monday.

Sinovac, the manufacturer of CoronaVac Vaccine, has applied for registration of its vaccine for use with children aged three years and over, Public Health Minister Anutin Charnvirakul said on Monday.

A third booster dose of a COVID-19 vaccine from either AstraZeneca Plc (NASDAQ: AZN), Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ:

BEIJING: More than two years into the pandemic most countries are striving to live alongside Covid, accepting the virus as part of everyday life. China, where the pathogen first emerged, exists in an alternate reality, wedded to a zero-tolerance strategy that’s growing harder to maintain.